Press Releases

Exact Sciences Corp. today announced that it will present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York. Kevin T. Conroy, Exact’s president and chief executive, will make the company’s presentation...

Exact Sciences Corp. today announced that it will present at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York. Kevin T. Conroy, Exact’s president and chief executive, will make the company’s presentation...

ERYTECH Pharma, a late stage biopharmaceuticals company focused on orphan oncology and rare diseases, announced today that it has entered into a definitive agreement with Orphan Europe, part of the Recordati Group, granting Orphan Europe exclusive rights for...

Genzyme, aSanofi company, announced today that the Australian Therapeutic Goods Administration (TGA) has approved AUBAGIO® (teriflunomide) 14 mg as a new once-daily, oral treatment indicated for patients with relapsing forms of multiple sclerosis (MS). The TGA approval will...

PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, announced today that it has opened direct operations in Midrand, South Africa. The new PerkinElmer Southern African headquarters...

Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain...

On November 19, 2012, the Juvenile Diabetes Cure Alliance announced the release of their annual research report, State of the Cure, which is the only analytical and comprehensive review of progress made toward a type 1 diabetes cure...